Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic and Predictive Value of PBRM1 in Clear Cell Renal Cell Carcinoma
Lucía Carril-Ajuria, María Santos, Juan María Roldán‐Romero, et al.
Cancers (2019) Vol. 12, Iss. 1, pp. 16-16
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma
Matteo Rosellini, Andrea Marchetti, Veronica Mollica, et al.
Nature Reviews Urology (2022) Vol. 20, Iss. 3, pp. 133-157
Closed Access | Times Cited: 152
Genomics of Clear-cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis
Oanh Bui, Tu Van Dao, Tai Van Nguyen, et al.
European Urology (2022) Vol. 81, Iss. 4, pp. 349-361
Open Access | Times Cited: 89
Circular RNAs in renal cell carcinoma: implications for tumorigenesis, diagnosis, and therapy
Ying Wang, Yunjing Zhang, Ping Wang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 80
Obesity alters the fitness of peritumoral adipose tissue, exacerbating tumor invasiveness in renal cancer through the induction of ADAM12 and CYP1B1
Sepehr Torabinejad, Caterina Miro, Annarita Nappi, et al.
Molecular Oncology (2025)
Open Access | Times Cited: 1
The Value of PD-L1 Expression as Predictive Biomarker in Metastatic Renal Cell Carcinoma Patients: A Meta-Analysis of Randomized Clinical Trials
Alberto Carretero-González, David Lora, Isabel Martín Sobrino, et al.
Cancers (2020) Vol. 12, Iss. 7, pp. 1945-1945
Open Access | Times Cited: 69
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma
Antonella Argentiero, Antonio Giovanni Solimando, Markus Krebs, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 5, pp. 1594-1594
Open Access | Times Cited: 61
Microplastics in freshwater sediments: Analytical methods, temporal trends, and risk of associated organophosphate esters as exemplar plastics additives
Simeon Onoja, Holly Nel, Mohamed Abou‐Elwafa Abdallah, et al.
Environmental Research (2021) Vol. 203, pp. 111830-111830
Open Access | Times Cited: 47
Prognostic Factors for Localized Clear Cell Renal Cell Carcinoma and Their Application in Adjuvant Therapy
Kalle Mattila, Paula Vainio, Panu Jaakkola
Cancers (2022) Vol. 14, Iss. 1, pp. 239-239
Open Access | Times Cited: 33
Genomic analysis uncovers prognostic and immunogenic characteristics of ferroptosis for clear cell renal cell carcinoma
Dan Bai, Huhu Feng, Jiajun Yang, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 25, pp. 186-197
Open Access | Times Cited: 35
Roles of the Dynamic Tumor Immune Microenvironment in the Individualized Treatment of Advanced Clear Cell Renal Cell Carcinoma
Enyu Lin, Xuechao Liu, Yanjun Liu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 31
Identification and validation of the clinical roles of the VHL-related LncRNAs in clear cell renal cell carcinoma
Wuping Yang, Jingcheng Zhou, Kenan Zhang, et al.
Journal of Cancer (2021) Vol. 12, Iss. 9, pp. 2702-2714
Open Access | Times Cited: 31
The SWI/SNF chromatin remodeling factor DPF3 regulates metastasis of ccRCC by modulating TGF-β signaling
Huanhuan Cui, Hongyang Yi, Hongyu Bao, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 20
Multiregional single-cell proteogenomic analysis of ccRCC reveals cytokine drivers of intratumor spatial heterogeneity
Natalia Miheecheva, Ekaterina Postovalova, Yang Lyu, et al.
Cell Reports (2022) Vol. 40, Iss. 7, pp. 111180-111180
Closed Access | Times Cited: 20
Comprehensive analyses of PBRM1 in multiple cancer types and its association with clinical response to immunotherapy and immune infiltrates
Qiuan Yang, Rong Shen, Hanlin Xu, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 6, pp. 465-465
Open Access | Times Cited: 24
Next-generation sequencing: unraveling genetic mechanisms that shape cancer immunotherapy efficacy
Ahmed Halima, Winston Vuong, Timothy A. Chan
Journal of Clinical Investigation (2022) Vol. 132, Iss. 12
Open Access | Times Cited: 18
PBRM1 bromodomains associate with RNA to facilitate chromatin association
Saumya M. De Silva, Alisha Dhiman, Surbhi Sood, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 8, pp. 3631-3649
Open Access | Times Cited: 10
JARID2 and EZH2, the eminent epigenetic drivers in human cancer
Bhuvanadas Sreeshma, Arikketh Devi
Gene (2023) Vol. 879, pp. 147584-147584
Closed Access | Times Cited: 10
The prognostic impact of PBRM1 immunohistochemical expression and its association with CD3+ and CD8+ immune cells in patients with renal cell carcinoma: A retrospective study
Amira Emad Elwy, Mahmoud Nassar, Shimaa Hassan Shaban, et al.
Pathology - Research and Practice (2025) Vol. 268, pp. 155863-155863
Closed Access
Platelet Count as an Independent Prognostic Marker in Clear Cell Renal Cell Carcinoma: Insights from Multi-source Data Analysis
Cong Huang, Jialong Zhang, Hongzhi Wang, et al.
Research Square (Research Square) (2025)
Closed Access
Biology of renal cancer tumor thrombus - towards the personalized approach
Sumit Sharma, Michał Kunc, Mieszko Czapliński, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104731-104731
Closed Access
Prediction tools for assessing functional impacts of gene mutations in Clear Cell Renal Cell Carcinoma: A comparative study
Cheng‐Hong Yang, Guan‐Cheng Lin, Chih-Hsien Wu, et al.
Computers in Biology and Medicine (2025) Vol. 192, pp. 110187-110187
Closed Access
A cytoskeletal function for PBRM1 reading methylated microtubules
Menuka Karki, Rahul K. Jangid, Ramakrishnan Anish, et al.
Science Advances (2021) Vol. 7, Iss. 14
Open Access | Times Cited: 22
From Bench to Bedside: How the Tumor Microenvironment Is Impacting the Future of Immunotherapy for Renal Cell Carcinoma
Jonathan F. Anker, Justin Miller, Nicole Taylor, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 3231-3231
Open Access | Times Cited: 21
Chromatin remodeling (SWI/SNF) complexes, cancer, and response to immunotherapy
Nithya Krishnamurthy, Shumei Kato, Scott M. Lippman, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 9, pp. e004669-e004669
Open Access | Times Cited: 16
The incidence, pathogenesis, and management of non-clear cell renal cell carcinoma
Priyanka Naik, Harshitha Dudipala, Yu‐Wei Chen, et al.
Therapeutic Advances in Urology (2024) Vol. 16
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top